High‐resolution crystal structures of the photoreceptor glyceraldehyde 3‐phosphate dehydrogenase (GAPDH) with three and four‐bound NAD molecules

Glyceraldehyde‐3‐phosphate dehydrogenase (GAPDH) catalyzes the oxidative phosphorylation of d‐glyceraldehyde 3‐phosphate (G3P) into 1,3‐diphosphoglycerate (BGP) in the presence of the NAD cofactor. GAPDH is an important drug target because of its central role in glycolysis, and nonglycolytic processes such as nuclear RNA transport, DNA replication/repair, membrane fusion and cellular apoptosis. Recent studies found that GAPDH participates in the development of diabetic retinopathy and its progression after the cessation of hyperglycemia. Here, we report two structures for native bovine photoreceptor GAPDH as a homotetramer with differing occupancy by NAD, bGAPDH(NAD)4, and bGAPDH(NAD)3. The bGAPDH(NAD)4 was solved at 1.52 Å, the highest resolution for GAPDH. Structural comparison of the bGAPDH(NAD)4 and bGAPDH(NAD)3 models revealed novel details of conformational changes induced by cofactor binding, including a loop region (residues 54–56). Structure analysis of bGAPDH confirmed the importance of Phe34 in NAD binding, and demonstrated that Phe34 was stabilized in the presence of NAD but displayed greater mobility in its absence. The oxidative state of the active site Cys149 residue is regulated by NAD binding, because this residue was found oxidized in the absence of dinucleotide. The distance between Cys149 and His176 decreased upon NAD binding and Cys149 remained in a reduced state when NAD was bound. These findings provide an important structural step for understanding the mechanism of GAPDH activity in vision and its pathological role in retinopathies.

[1]  Ritu Chakravarti,et al.  GAPDH regulates cellular heme insertion into inducible nitric oxide synthase , 2010, Proceedings of the National Academy of Sciences.

[2]  J. Mornon,et al.  Functional characterization of the phosphorylating D-glyceraldehyde 3-phosphate dehydrogenase from the archaeon Methanothermus fervidus by comparative molecular modelling and site-directed mutagenesis. , 1999, European journal of biochemistry.

[3]  J. Stamler,et al.  Posttranslational Modification of Glyceraldehyde-3-phosphate Dehydrogenase by S-Nitrosylation and Subsequent NADH Attachment (*) , 1996, The Journal of Biological Chemistry.

[4]  E. Kuzminskaya,et al.  Rabbit muscle D-glyceraldehyde-3-phosphate dehydrogenase: half-of-the-sites reactivity of the enzyme modified at arginine residues. , 1992, Biochemical and biophysical research communications.

[5]  Randy J. Read,et al.  Phaser crystallographic software , 2007, Journal of applied crystallography.

[6]  J. Dawson,et al.  Heme binding properties of glyceraldehyde-3-phosphate dehydrogenase. , 2012, Biochemistry.

[7]  Y. Ho,et al.  Role of mitochondrial superoxide dismutase in the development of diabetic retinopathy. , 2006, Investigative ophthalmology & visual science.

[8]  A. Sawa,et al.  GAPDH as a sensor of NO stress. , 2006, Biochimica et biophysica acta.

[9]  M. Grütter,et al.  Structure of rabbit-muscle glyceraldehyde-3-phosphate dehydrogenase. , 2003, Acta crystallographica. Section D, Biological crystallography.

[10]  J. Alikhajeh,et al.  Crystal structures of rice (Oryza sativa) glyceraldehyde-3-phosphate dehydrogenase complexes with NAD and sulfate suggest involvement of Phe37 in NAD binding for catalysis , 2012, Plant Molecular Biology.

[11]  S. Madsen-Bouterse,et al.  Glyceraldehyde-3-phosphate dehydrogenase in retinal microvasculature: implications for the development and progression of diabetic retinopathy. , 2010, Investigative ophthalmology & visual science.

[12]  J. Baynes,et al.  Inactivation of Glyceraldehyde-3-Phosphate Dehydrogenase by Fumarate in Diabetes , 2008, Diabetes.

[13]  S. Snyder,et al.  Nitric Oxide–GAPDH–Siah: A Novel Cell Death Cascade , 2006, Cellular and Molecular Neurobiology.

[14]  John J Tanner,et al.  High-resolution structure of human D-glyceraldehyde-3-phosphate dehydrogenase. , 2006, Acta crystallographica. Section D, Biological crystallography.

[15]  W. Stell,et al.  Endogenous nitric oxide enhances the light-response of cones during light-adaptation in the rat retina , 2011, Vision Research.

[16]  C. Chiu,et al.  Dietary hyperglycemia, glycemic index and metabolic retinal diseases , 2011, Progress in Retinal and Eye Research.

[17]  T. Kern,et al.  Hyperglycemia increases mitochondrial superoxide in retina and retinal cells. , 2003, Free radical biology & medicine.

[18]  Conrad C. Huang,et al.  Visualizing density maps with UCSF Chimera. , 2007, Journal of structural biology.

[19]  N. Colloc'h,et al.  Comparative study of the catalytic domain of phosphorylating glyceraldehyde-3-phosphate dehydrogenases from bacteria and archaea via essential cysteine probes and site-directed mutagenesis. , 1998, European journal of biochemistry.

[20]  Randy J. Read,et al.  Overview of the CCP4 suite and current developments , 2011, Acta crystallographica. Section D, Biological crystallography.

[21]  N. Seidler Basic biology of GAPDH. , 2013, Advances in experimental medicine and biology.

[22]  Michael Brownlee,et al.  The pathobiology of diabetic complications: a unifying mechanism. , 2005, Diabetes.

[23]  R. Molday,et al.  Glyceraldehyde-3-phosphate dehydrogenase is a major protein associated with the plasma membrane of retinal photoreceptor outer segments. , 1990, The Journal of biological chemistry.

[24]  M G Rossmann,et al.  Comparison of super-secondary structures in proteins. , 1973, Journal of molecular biology.

[25]  M A Sirover,et al.  New insights into an old protein: the functional diversity of mammalian glyceraldehyde-3-phosphate dehydrogenase. , 1999, Biochimica et biophysica acta.

[26]  Vincent B. Chen,et al.  Correspondence e-mail: , 2000 .

[27]  C. Huang,et al.  Circadian phase‐dependent effect of nitric oxide on L‐type voltage‐gated calcium channels in avian cone photoreceptors , 2013, Journal of neurochemistry.

[28]  G. N. Ramachandran,et al.  Stereochemistry of polypeptide chain configurations. , 1963, Journal of molecular biology.

[29]  M. Sirover On the functional diversity of glyceraldehyde-3-phosphate dehydrogenase: biochemical mechanisms and regulatory control. , 2011, Biochimica et biophysica acta.

[30]  J. Frayne,et al.  Structure of Insoluble Rat Sperm Glyceraldehyde-3-phosphate Dehydrogenase (GAPDH) via Heterotetramer Formation with Escherichia coli GAPDH Reveals Target for Contraceptive Design* , 2009, The Journal of Biological Chemistry.

[31]  A. Whorton,et al.  S-nitrosoglutathione reversibly inhibits GAPDH by S-nitrosylation. , 1995, The American journal of physiology.

[32]  Kevin Cowtan,et al.  research papers Acta Crystallographica Section D Biological , 2005 .

[33]  Conrad C. Huang,et al.  UCSF Chimera, MODELLER, and IMP: an integrated modeling system. , 2012, Journal of structural biology.

[34]  P. Vachette,et al.  P but not R-axis interface is involved in cooperative binding of NAD on tetrameric phosphorylating glyceraldehyde-3-phosphate dehydrogenase from Bacillus stearothermophilus. , 2003, Journal of molecular biology.

[35]  S. Ismail,et al.  Structural analysis of human liver glyceraldehyde-3-phosphate dehydrogenase. , 2005, Acta crystallographica. Section D, Biological crystallography.

[36]  Z. Otwinowski,et al.  Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.

[37]  L. Foster,et al.  Proteomics of Photoreceptor Outer Segments Identifies a Subset of SNARE and Rab Proteins Implicated in Membrane Vesicle Trafficking and Fusion *S , 2008, Molecular & Cellular Proteomics.

[38]  E. Fanchon,et al.  Comparison of the structures of wild-type and a N313T mutant of Escherichia coli glyceraldehyde 3-phosphate dehydrogenases: implication for NAD binding and cooperativity. , 1996, Journal of molecular biology.

[39]  M. Rossmann,et al.  Structure determination of crystalline lobster D-glyceraldehyde-3-phosphate dehydrogenase. , 1974, Journal of molecular biology.

[40]  Fei Long,et al.  REFMAC5 dictionary: organization of prior chemical knowledge and guidelines for its use. , 2004, Acta crystallographica. Section D, Biological crystallography.